Ugne Balaseviciute

Also affiliated with Departament de Salut, Mount Sinai Hospital, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Icahn School of Medicine at Mount Sinai

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma”.

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0725

N/A

0.282DataRank · unranked

5 citations

Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen +21 more

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2517

N/A

0DataRank · unranked

78 citations

Catherine E. Willoughby, Marta Piqué-Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0335

N/A

0DataRank · unranked

15 citations

Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute +24 more

Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22482765.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.12.016

N/A

0DataRank · unranked

44 citations

Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol +36 more

Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

JHEP Reports(2025)10.1016/j.jhepr.2025.101592

N/A

0DataRank · unranked

3 citations

Agavni Mesropian, Laura Žigutytė, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver +13 more

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

Hepatology(2021)10.1002/hep.32023

N/A

0DataRank · unranked

164 citations

Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber +15 more

Effective therapeutic targeting of CTNNB1 ‐mutant hepatoblastoma with WNTinib

Molecular Oncology(2025)10.1002/1878-0261.70168

N/A

0DataRank · unranked

0 citations

Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez +13 more